Has Steven Goldfarb, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,573 in general payments to Steven Goldfarb, MD across 43 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Goldfarb, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Goldfarb, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Goldfarb, MD

Sports Medicine · Cincinnati, OHNPI 1346256443

Payments from drug & device makers

$3,573in general payments, 2019–2025

Across 43 payments — averaging $83.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Exactech, Inc.$2K
Zimmer Biomet$470
Johnson & Johnson$240
Pacira Therapeutics, Inc.$158
BD$149
Smith+Nephew$146
plus $209 from 4 others

What the payments were for

Consulting fees$1,71248%
Food & beverage$1,44140%
Education$42012%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Exactech, Inc.	9	$2,200
Zimmer Biomet	4	$470
Johnson & Johnson	8	$240
Pacira Therapeutics, Inc.	7	$158
BD	2	$149
Smith+Nephew	1	$146
Ferring Pharmaceuticals Inc.	7	$124
Boston Scientific	1	$48
Sanofi-aventis U.S. LLC	2	$31
Heron Therapeutics, Inc.	2	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,573 in reported general payments places this provider in the 65th percentile of 278 sports medicine providers in Ohio.

See all sports medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$278,250

Medicare patients

388

Services billed

1,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	189	$1,229
Ondansetron Hcl	112	$812
Methocarbamol	96	$369
Gabapentin	123	$332
Amoxicillin	194	$186
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	22	$179
Clindamycin Hcl	48	$91
Methylprednisolone	18	$86
Tramadol Hcl	23	$76
Doxycycline Hyclate	11	$55

Paid to pharmacies, not to this prescriber.

Other sports medicine in Cincinnati

Robert HeidtCincinnati$911K
Vincent SammarcoCincinnati$361K
Brian GraweCincinnati$293K
Frank NoyesCincinnati$244K
Melissa SummersCincinnati$89K
Timothy KremchekCincinnati$28K
George MaticCincinnati$22K
Michelle AndrewsCincinnati$22K
Ian RiceCincinnati$14K
Samir SharrakCincinnati$12K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →